(Q32022492)

5 July 2017

1 reference

title

Iron chelation therapy in sickle cell disease (English)

1 reference

5 July 2017

0 references

0 references

Cohen AR

1

1 reference

5 July 2017

Martin MB

series ordinal

2

1 reference

5 July 2017

publication date

1 January 2001

1 reference

5 July 2017

published in

Seminars in Hematology

1 reference

5 July 2017

volume

38

1 reference

5 July 2017

issue

1 Suppl 1

1 reference

5 July 2017

page(s)

69-72

1 reference

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Depletion of excessive liver iron stores with desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Excretion of iron in response to deferoxamine in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Iron chelation therapy in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Survival in medically treated patients with homozygous beta-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Combined therapy with deferiprone and desferrioxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

Survival and causes of death in thalassaemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990062-9

7 January 2021

10.1016/S0037-1963(01)90062-9

Identifiers

DOI

1 reference

5 July 2017

1 reference